Dr. Karim Galil was tired. He was tired of losing patients to cancer. He was tired of messy medical records. And he was tired of trying to stay on top of the avalanche of clinical trials touting one solution or another. Losing both patience and too many patients, Galil decided to create an organized and artificially intelligent system to match those under his care with the best diagnostic and treatment methods available.
He called his new system Mendel.ai after Gregor Mendel, the father of modern genetics science, and has just raised $2 million in seed funding from DCM Ventures, Bootstrap Labs and Launch Capital to get the project off the ground.
Mendel.ai is similar in many ways to the U.K.-based BenevolentBio, which is focused on skimming through scientific papers to find the latest in cutting-edge medical research. But rather than using keyword data, Mendal.ai uses an algorithm that understands the unstructured, natural language content within…